AMPICILLIN SODIUM Recall D-0583-2023
Description: Ampicillin for Injection, USP 2g per vial, Rx only, Mfg. for: Piramal Critical Care, Bethlehem, PA 18017 USA, NDC 66794-223-41
AMPICILLIN SODIUM Recall D-0583-2023 Information
| Status | Ongoing |
| Mandated? | Voluntary: Firm initiated |
| Recall Number | D-0583-2023 |
| Event ID | 92341 |
| Brand | AMPICILLIN |
| Generic Name | AMPICILLIN |
| Manufacturer | AMPICILLIN |
| Original Package? | 1 |
| Active Substance | AMPICILLIN SODIUM |
| Drug Route | INTRAMUSCULAR |
| Distribution | Nationwide within the United States |
| Quantity | 45,160 vials |
| Recall Reason | Lack of Assurance of Sterility |
| Drug Classification | Class II |
| Drug Code Info | 20230524 |
| Product NDC | 66794-220 66794-222 66794-223 |
| Drug UPC | 0366794223026 0366794220025 |
| Recall Initiation Date | 20230515 |
| Report Date | 20230524 |
| Classification Date | 20230518 |
| Address | 911 G I D C Makarpura Vadodara, India |
| Recalling Firm | Astral SteriTech Private Ltd. |
| Initial Notification | Letter |
| Unique Ingredient Identifier | JFN36L5S8K |
| Drug Application Number | ANDA090583 |
| Structured Product Labeling (SPL ID) | f091d2b5-3f8e-1060-e053-2995a90a1697 |
| Structured Product Labeling (SPL Set ID) | 9231bd4f-53b6-04bb-e053-2a95a90a774b |
| Similar To |